Kidney Cancer Trial, Recruiting (NCT07540260)

Kidney Cancer Trial, Recruiting NCT07540260 Sponsor: Peking University First Hospital Condition: Kidney Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07540260 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Kidney Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
Your kidney cancer has been confirmed by a tissue sample (biopsy) as a specific type called "clear cell renal cell carcinoma"
Your cancer has come back after previous treatment or has spread to other parts of the body
You are already receiving or are about to start a first-line treatment combining a targeted therapy drug with an immunotherapy drug
You have had, or are able to have, two specific types of PET/CT scans, and your doctors have confirmed you are suitable for radiation therapy planning
A team of specialists has agreed that radiation therapy could be used to treat at least 75% of the visible tumours in your body
You are able and willing to sign a consent form agreeing to take part in the study

Who may not be able to join:

You are unable to receive the specific type of precision radiation therapy (called stereotactic radiotherapy) that the trial requires
You have other serious health conditions that are not well controlled, or you currently have an active infection
You are pregnant or breastfeeding
You are unable or unwilling to follow the study procedures and attend the required follow-up appointments

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-13693556512

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07540260

Sponsor: Peking University First Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Kidney Cancer

Trial contact: +86-13693556512

More information: https://clinicaltrials.gov/study/NCT07540260

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
Your kidney cancer has been confirmed by a tissue sample (biopsy) as a specific type called "clear cell renal cell carcinoma"
Your cancer has come back after previous treatment or has spread to other parts of the body
You are already receiving or are about to start a first-line treatment combining a targeted therapy drug with an immunotherapy drug
You have had, or are able to have, two specific types of PET/CT scans, and your doctors have confirmed you are suitable for radiation therapy planning
A team of specialists has agreed that radiation therapy could be used to treat at least 75% of the visible tumours in your body
You are able and willing to sign a consent form agreeing to take part in the study

Who may not be able to join:

You are unable to receive the specific type of precision radiation therapy (called stereotactic radiotherapy) that the trial requires
You have other serious health conditions that are not well controlled, or you currently have an active infection
You are pregnant or breastfeeding
You are unable or unwilling to follow the study procedures and attend the required follow-up appointments

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Peking University First Hospital

Registry

ClinicalTrials.gov

Start date

1 November 2025

Est. completion

31 December 2030

Where this trial is recruiting

🇨🇳 China

Primary endpoints

PFS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov